The distribution agreement and initial purchase purchase from Adachi signifies an important stage in expanding the marketplace for Renaissance in Asia, said Ori Hadomi, CEO of Mazor. Adachi can be an 80 year-previous family-owned business which has established interactions with leading hospitals and medical companies. It has significant knowledge in distributing leading medical technology and clearing the regulatory hurdles. We're so pleased to enter the Japanese market with Adachi seeing that our partner. Renaissance, Mazor Robotics' next era surgical guidance system for spine methods, is transforming spine surgery from freehand procedures to highly-accurate, state-of-the-art methods, with less radiation – also for minimally invasive medical procedures, scoliosis, and other complicated spinal deformity cases.‘We are retaining critically important commercial value through significant global royalties, regulatory and product sales milestones and a co-promotion option and eliminating the necessity for us to fund fifty % of the ridaforolimus costs. This will allow us to target our assets on commencing the pivotal trial for our next promising product applicant – AP24534 – our investigational pan BCR-ABL inhibitor and on advancing development of AP26113 – our investigational ALK inhibitor.’.. 40 percent of Canadians admit to having kissed a stranger under the mistletoe It’s no real surprise that Canadians smile and kiss more through the holiday season.